icgs2018
Beaver
oftalmolog_club
YouTube
glaucoma_net_ru
camopht
bannerparasol
профессор
askin_heid
nidek
конгресс 2018
eye5
icglaucoma.org
Шахматы
varthamana2
Конгресс
Первая пятница декабря
www.worldglaucoma.org
facebook
Ассоциации
Основные мероприятия ассоциации офтальмологов
Торика
АйНьюс.РФ
cophyaa
appstore
medlab
cophyeu
santen
Флаги
ВК
Mobile
Конгресс 2014
Новости офтальмологии
Purpose: We describe a patient with primary angle-closure glaucoma who developed malignant glaucomafollowing laser peripheral iridotomy.
Премия «Золотой лорнет» за пять лет развития стала традиционным местом испытания для участников рынка медицинской оптики: товаров и услуг, оборудования и расходных материалов, очковых и контактных линз, солнцезащитных очков и медицинских оправ, дистрибуторских и розничных сетей, а также магазинов оптики в России. Конкурс содействует созданию и развитию Программы сохранения здоровья зрения населения России как важнейшей задачи оптической индустрии в целом; консолидирует и развивает национальный рынок оптических товаров и услуг, выявляет и поддерживает лидеров оптического рынка страны, повышает знание и формирует благоприятное отношение конечных потребителей к офтальмологии и оптике, и, в целом, стимулирует развитие деловой активности отечественного предпринимательства.
Purpose: Tetracaine is one of the most common eye drops that are used for analgesia in clinical practice. However, it causes ocular burning sensation when instilled. This study aimed to compare the effects of the cold and room temperature tetracaine on burning sensation. Patients and methods: We conducted a prospective, double-blinded, randomized controlled trial at the ophthalmology outpatient clinic, Phramongkutklao Hospital during January 2016–February 2017. In this study, 424 consecutive patients (those with a history of keratopathy or neuropathy were excluded) who received dilated fundus examination were randomized to receive cold tetracaine (4°C) in one eye and room temperature tetracaine (22.5°C) in the other eye. Each patient was asked to answer the questionnaire on the severity of burning sensation using 100 mm visual analog scale. Results: Patients reported less burning sensation on the eye that received cold tetracaine (visual analog scale 20.50±18.8 vs 22.70±20 mm; P=0.025). In the subgroup analysis, young patients (≤40 years old), female subjects, patients who received tetracaine for the first-time and those who had no previous ocular surgery reported more benefit from cold tetracaine. The subgroup of patients who had normal corneal sensation, identified by using a Cochet–Bonnet esthesiometer, also showed greater benefit from cold tetracaine compared to those with impaired corneal sensation. Conclusion: Cold tetracaine caused less burning sensation than room temperature solution. Its benefit was greater in the subgroup of patients who reported more severe burning sensation. We recommend using cold tetracaine in routine practice, especially in those who are anticipated to have this common side effect.
Лет 5 назад мы проводили симпозиум на эту тему. Помню, выступали проф. Малюгин, проф. Трубилин и еще несколько коллег! Почитаем, что пишут зарубежные авторы?
Retina World Congress is a non-profit organization dedicated to uniting international professionals to foster dialogue and to generate consensus about retinal diseases, emerging technologies and treatments, best practices and clinical research. Our biennial meeting is our main initiative and has brought together 150 faculty and 1,000 attendees from 32 U.S. states, 74 countries and 39 retina societies from around the globe. We unite again in 2019 to share research, innovations and ideas with a growing audience... and we want you to be a part of it!
OCT imaging has become an indispensable tool in uveitis practice. It is the standard diagnostic technique in the detection, monitoring of treatment, and determination of prognosis in uveitic macular edema (ME) as well as in other macular and extramacular inflammatory changes. OCT technology has evolved in the last 2 decades from time domain OCT (TD-OCT) to spectral domain OCT (SD-OCT) and recently to the enhanced-depth imaging OCT (EDI-OCT) and Topcon’s Swept Source OCT (SS-OCT).1
Important dates Abstract Deadline: September 7, 2018 Abstract Notification: September 26, 2018 Early-bird Registration ends: September 29, 2018 Visa Request Deadline: October 26, 2018 Regular Registration ends: October 31, 2018 Wetlab and Workshop Registration ends: November 9, 2018
Background: The prevalence of bacterial pathogens isolated from patients with acute and chronic dacryocystitis and the pattern of antibiotic susceptibility tests are varied in each region. Moreover, the management of dacryocystitis is only based on clinical observations without microbiological evaluation. The present study aimed to identify epidemiologic and etiologic factors of dacryocystitis in our geographical area
Abstract: Preservatives used in topical glaucoma medications have a plethora of well-described toxic effects on the ocular surface. Such ocular toxicity is manifest clinically as ocular surface disease (OSD) and has been confirmed in epidemiologic, prospective clinical trials and studies in which patients are switched from preservative-added to preservative-free topical therapy. Such toxicity has implications not only for tolerability, but also for adherence and persistence with therapy that is known to be poor in glaucoma. Glaucoma medication is now widely avail- able in preservative-free formulations, and the question arises as to which patients should receive preservative-free glaucoma therapy in preference to preservative-added medication. A case can be made for several subpopulations of patients who might particularly benefit from preservative-free medication: patients with existing OSD, older patients, younger adult patients, female patients, pediatric and juvenile patients, patients who work in air-conditioned environ- ments or who use electronic screens frequently, patients with medical risk factors for OSD, patients in whom trabecular surgery may become indicated in the future, contact lens users, perhaps patients with Asian ethnicity and patients with severe or treatment-refractory glaucoma. Whilst arguments could be made for selecting patients for preservative-free medication on the basis of their existing risk of OSD, collectively, these patients form a significant proportion of the glaucoma patient population as a whole and, in the absence of any cost premium or positive indication for preservative-added medication, preservative-free glaucoma medication for all patients seems an appropriate strategy.
Официально получено Российским глаукомным обществом от Национальной медицинской палаты
Because glaucoma typically begins by affecting the far periphery of the vision, most patients are unaware that they have the disease until it progresses and destroys central vision. As a result, nearly half of those with glaucoma remain undiagnosed, and 50% have advanced disease at the time of diagnosis. Since glaucoma-related vision loss is permanent and treatment can slow progression and prevent blindness in 90% of cases, regular screening of at-risk patients to detect and treat glaucoma early is both worthwhile and recommended.
Samuel F Passi,* Atalie C Thompson,* Preeya K Gupta Department of Ophthalmology, Duke University Eye Center, Durham, NC, USA *These authors contributed equally to this work Purpose: To compare the agreement and efficiency of a swept source-optical coherence tomography biometer, IOLMaster 700 (IOLM700), and a low-coherence optical reflectometry biometer, LENSTAR LS 900 (LS900), when acquiring biometry measurements during cataract evaluation.
Полезнейшая, на мой взгляд, конференция)
Purpose: The purpose of this study was to characterize a pilot program using e-health to monitor glaucoma suspects in a large integrated health system.
Lausanne, Switzerland, October 3rd 2018, Sensimed is pleased to announce the registration of the SENSIMED Triggerfish® sensor and monitoring system as a medical device in Japan. The Japanese partner and distributor of Sensimed, SEED Co., Ltd., has obtained the approval from the Ministry of Health, Labour and Welfare. The device will be available for sale towards the end of 2018.
31st October 2018 4pm CET Astigmatism has a high prevalence in cataract patients. Up to 70% of patients are candidates for astigmatism correction with toric IOLs 1. Both preoperative astigmatism and postoperative residual astigmatism affect visual function and vision-related quality of life. The surgical correction of astigmatism is the last frontier to optamizing visual outcomes for the patients. Post-operative refractive surprises are largely due to the assessment and management of pre-operative and intra-operative refractive variables2-4. VERION™ System 3.1 provides a new and improved way of looking at cataract surgery, helping to minimize potential sources of error during each step of the surgical process5.
Уважаемый коллега! Приглашаем Вас принять участие в работе Республиканской конференции с международным участием «Актуальные вопросы офтальмологии (реальность, мифы и противоречия)», которая пройдет 14-15 декабря 2018 года в г. Минске на базе Белорусской медицинской академии последипломного образования по адресу: г. Минск, ул. П. Бровки, 3, корп. 3. Начало работы конференции 14 декабря 2018 года в 9.00.
nvestigators sought to identify possible associations between the consumption of various beverages, including caffeinated and decaffeinated iced or hot coffee, caffeinated and decaffeinated iced or hot tea, and soft drinks, and a diagnosis of glaucoma. This retrospective, cross-sectional study was conducted using data from the 2005-2006 National Health and Nutrition Examination Survey (NHANES), which queried participants about the frequency of their consumption of the aforementioned beverages
Голосование
Что "заставляет" Вас заниматься научными исследованиями?
Популярная пресса
Фотогалерея
Интересное видео
Книги-новинки
Клуб молодых офтальмологов

МОО "Глаукомное общество"

Экспертный совет по глаукоме

Диабет. Рекомендации

Глаукома. Рекомендации ICO

Новостная лента на Twitter
Новости зарубежной офтальмологии